HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

What is the role of dipyridamole in long-term secondary prevention after an ischemic stroke or transient ischemic attack?

AuthorsCathie Sudlow
JournalCMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne (CMAJ) Vol. 173 Issue 9 Pg. 1024-6 (Oct 25 2005) ISSN: 1488-2329 [Electronic] Canada
PMID16247094 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S., Review)
Chemical References
  • Platelet Aggregation Inhibitors
  • Dipyridamole
  • Aspirin
Topics
  • Aspirin (pharmacology, therapeutic use)
  • Dipyridamole (adverse effects, therapeutic use)
  • Evidence-Based Medicine
  • Humans
  • Ischemic Attack, Transient (prevention & control)
  • Platelet Aggregation Inhibitors (adverse effects, therapeutic use)
  • Randomized Controlled Trials as Topic
  • Stroke (prevention & control)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: